By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical Co., Inc. (HTSUY)

OTC Currency in USD
$6.80
$0.00
0.00%
Last Update: 2 Sept 2025, 00:00
$1.98B
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$6.75 - $7.30
52 Week Range

HTSUY Stock Price Chart

Explore Hisamitsu Pharmaceutical Co., Inc. interactive price chart. Choose custom timeframes to analyze HTSUY price movements and trends.

HTSUY Company Profile

Discover essential business fundamentals and corporate details for Hisamitsu Pharmaceutical Co., Inc. (HTSUY) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

IPO Date

Employees

2.77K

CEO

Description

Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.

HTSUY Financial Timeline

Browse a chronological timeline of Hisamitsu Pharmaceutical Co., Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 8 Apr 2026

Upcoming earnings on 7 Jan 2026

Upcoming earnings on 8 Oct 2025

Earnings released on 10 Jul 2025

Earnings released on 10 Apr 2025

EPS came in at $0.18 , while revenue for the quarter reached $290.57M .

Earnings released on 9 Jan 2025

Earnings released on 10 Oct 2024

EPS came in at $0.10 , while revenue for the quarter reached $39.65B .

Earnings released on 11 Jul 2024

EPS came in at $0.04 , while revenue for the quarter reached $265.11M .

Earnings released on 30 May 2024

EPS came in at $0.10 , while revenue for the quarter reached $233.57M .

Earnings released on 29 Nov 2023

EPS came in at $0.08 , while revenue for the quarter reached $240.52M .

Earnings released on 30 Aug 2023

EPS came in at $0.10 , while revenue for the quarter reached $244.82M .

Earnings released on 30 May 2023

EPS came in at $0.10 , while revenue for the quarter reached $237.99M .

Earnings released on 27 Feb 2023

EPS came in at $0.05 , while revenue for the quarter reached $274.46M .

Earnings released on 29 Nov 2022

EPS came in at $0.07 , while revenue for the quarter reached $223.90M .

Earnings released on 30 Aug 2022

EPS came in at $0.11 , while revenue for the quarter reached $245.60M .

Earnings released on 30 May 2022

EPS came in at $0.04 , while revenue for the quarter reached $212.09M .

Earnings released on 27 Feb 2022

EPS came in at $0.09 , while revenue for the quarter reached $292.46M .

Earnings released on 29 Nov 2021

EPS came in at $0.03 , while revenue for the quarter reached $250.04M .

Earnings released on 30 Aug 2021

EPS came in at $0.07 , while revenue for the quarter reached $279.73M .

Earnings released on 30 May 2021

EPS came in at $0.07 , while revenue for the quarter reached $254.88M .

HTSUY Stock Performance

Access detailed HTSUY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run